Women's Health Law Symposium, Rutgers School of Law-Newark, April 6, 1994.
D000163:Acquired Immunodeficiency Syndrome; D035843:Biomedical Research; D001943:Breast Neoplasms; D002585:Cesarean Section; D017579:Domestic Violence; D064420:Drug-Related Side Effects and Adverse Reactions; D035082:Federal Government; D005260:Female; D006076:Government; D033161:Government Regulation; D017408:Guidelines as Topic; D015386:Hazardous Substances; D018166:Health Care Reform; D006331:Heart Diseases; D006805:Human Experimentation; D006801:Humans; D007349:Insurance, Health, Reimbursement; D007603:Jurisprudence; D007743:Labor, Obstetric; D007878:Legislation as Topic; D008571:Men; D015969:National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division; D009316:National Institutes of Health (U.S.); D016273:Occupational Exposure; D005791:Patient Care; D018579:Patient Selection; D004364:Pharmaceutical Preparations; D011247:Pregnancy; D037841:Pregnant People; D011287:Prejudice; D011297:Prenatal Exposure Delayed Effects; D011640:Public Policy; D012106:Research; D012108:Research Personnel; D035842:Research Subjects; D012926:Social Control, Formal; D012959:Socioeconomic Factors; D016312:Treatment Refusal; D014481:United States; D014486:United States Food and Drug Administration; D035862:Vulnerable Populations; D014930:Women; D016387:Women's Health
Biomedical and Behavioral Research; Health Care and Public Health; Institute of Medicine; National Cancer Institute; National Institutes of Health